Long-term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real-world retrospective study.
作者信息
Chiricozzi Andrea, Gori Niccolò, Ippoliti Elena, Maurelli Martina, Antonelli Flaminia, Coscarella Giulia, Rizzo Elisabetta, Di Nardo Lucia, Girolomoni Giampiero, Peris Ketty
机构信息
Dermatologia, Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
出版信息
J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e892-e895. doi: 10.1111/jdv.19980. Epub 2024 Mar 27.
PMID:38534078
Abstract
摘要
相似文献
1
Long-term therapeutic response to dupilumab in patients affected by prurigo nodularis: A real-world retrospective study.
J Eur Acad Dermatol Venereol. 2024 Oct;38(10):e892-e895. doi: 10.1111/jdv.19980. Epub 2024 Mar 27.
2
Efficacy and safety of dupilumab in patients with prurigo nodularis.
Arch Dermatol Res. 2024 Oct 14;316(10):676. doi: 10.1007/s00403-024-03387-1.
3
Effectiveness and safety of dupilumab for the treatment of prurigo nodularis in a French multicenter adult cohort of 16 patients.
J Eur Acad Dermatol Venereol. 2020 Feb;34(2):e74-e76. doi: 10.1111/jdv.15957. Epub 2019 Oct 17.
4
Safety and Effectiveness of Dupilumab in Prurigo Nodularis.
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):162-163. doi: 10.18176/jiaci.0550. Epub 2020 Jun 23.
5
Dupilumab for pediatric prurigo nodularis: A case report.
Pediatr Dermatol. 2021 Jan;38(1):334-335. doi: 10.1111/pde.14464. Epub 2020 Nov 28.
6
Dramatic improvement of generalized prurigo nodularis with dupilumab.
J Eur Acad Dermatol Venereol. 2019 Aug;33(8):e303-e304. doi: 10.1111/jdv.15584. Epub 2019 May 8.
7
A critical review of dupilumab for adult patients with prurigo nodularis.
Expert Rev Clin Immunol. 2024 Mar;20(3):249-254. doi: 10.1080/1744666X.2023.2268291. Epub 2023 Oct 12.
8
Time is the answer: Dupilumab effectiveness in prurigo nodularis patients.
J Eur Acad Dermatol Venereol. 2024 Oct;38(10):1848-1849. doi: 10.1111/jdv.20295.
9
Dupilumab for treatment-refractory prurigo nodularis.
J Dtsch Dermatol Ges. 2020 Jun;18(6):618-624. doi: 10.1111/ddg.14107. Epub 2020 May 29.
10
Baseline eosinophil level may be a predictive indicator for the effectiveness of dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study.
J Am Acad Dermatol. 2024 May;90(5):1076-1078. doi: 10.1016/j.jaad.2024.01.036. Epub 2024 Jan 29.
Zotero 插件